International Congress of Scleral Contacts (ICSC) 2023

ReachMD Healthcare Image
Details
  • Overview

    During this conference, you can expect to learn more on topics such as differences around the world and 2023 updates, scleral lenses use, publication data, use in postsurgical cases, neurotropic keratitis and succeeding with multifocal lenses. ICSC will feature international top expert speakers presenting to a very interactive audience of optometrists, Scleral Lens Education Society Fellows, contact lens practitioners, and optometrists from around the world.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Understand the newest publication data and the effect on future use in scleral patients.
    • Implement best practices in postsurgical cases.
    • Identify the important steps in starting and succeeding in scleral practice.
    • Understand the clinical classification, diagnosing and management options in Neurotropic Keratitis
    • Accreditation

      Evolve is a COPE-Accredited Administrator.

      This activity, COPE Activity Number 126345, is accredited by COPE for continuing education for optometrists. This course is approved for 5 hours of CE.

      Course ID: 85239-CL, 85237-GO, 85176-CL, 84177-CL, 85179-CL, 85178-CL, 85298-GO
      Activity ID: 126345

      COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

      CE Broker approval #20-945377

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

      Course Viewing Requirements

      Supported Browsers:
      Internet Explorer 11 for Windows
      Edge (recent versions; Chromium-based) for Windows
      Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
      Safari (recent versions) for Mac OSX, or iOS

      Hardware Requirements:
      4GB+ RAM
      Recommended internet speed 5Mbps+

    • Faculty and Disclosures

      Melissa Barnett, OD, FAAO, FSLS, FBCLA

      Melissa Barnett, OD, FAAO, FSLS, FBCLA

      Principal Optometrist
      University of California, Davis, Eye Center
      Sacramento, CA


      Thomas P. Arnold, OD, FSLS

      Thomas P. Arnold, OD, FSLS

      Optometrist
      Memorial Eye Center
      Sugar Land, TX


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Melissa Barnett, OD, FAAO, FSLS, FBCLA, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Alcon, Acculens, Anthem, Inc., Bausch + Lomb, Contamac, EveryDay Contacts, Novabay, Ocusoft, Percept, Paragon Bioteck, Raayonnova, Scleral Lens Education Society, Shire, Synergeyes, and Vistakon, a division of Johnson & Johnson Vision Care. Speaker's Bureau: Allergan, Alcon, Alden Optical, Acculens, Bausch + Lomb, Contamac, CooperVision, Gas Permeable Lens Institute,Scleral Lens Education Society, Science Based Health, Shire, Sjogren's Syndrome Foundation, STAPLE Program, Synergeyes, Visioneering Technologies, and Vistakon, a division of Johnson & Johnson Vision Care. 

      Thomas P. Arnold, OD, FSLS, has had no financial relationship or affiliation with the following ineligible companies.

      Karen Carrasquillo, OD, PhD, FAAO, FSLS has had a financial relationship or affiliation with the following ineligible companies in the form of Employee: 501c3 BostonSight

      Greg DeNaeyer, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Visionary Optics, Alcon. Shareholder: Precision Ocular Metrology

      Jason Jedlicka, OD, FAAO has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Bausch + Lomb, Oculus, and Ovitz. Speaker’s Bureau: Esslior, Eaglet Eye, and Tangible Science. Shareholder: Lens Design Solutions

      Langis Michaud, OD, MSc, FAAO (Dipl), FSLS has had a financial relationship or affiliation with the following ineligible companies in the form of Grant / Research Support: Bausch + Lomb. Speakers Bureau: Cooper Vision and Essilor

      Andrew Morgenstern, OD, FAAO, FNAP has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: American Optometric Association, Chenega Health Services, LENZ Therapeutics, Optometric Strategic Investment Club, Oculus, and Tiero Health. Employee: International Keratoconus Academy.

      Sheila Morrison, OD, MS has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Euclid. Speaker’s Bureau: Paragon, Cooper Vision, Boston Site, Eaglet, Pentavision, Vistakon, and Euclid.

      Cherie Nau, OD has had no financial relationship or affiliation with ineligible companies.

      Javier Rojas-Viñuelas, OD has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Eaglet Eye. Grant / Research Support: Johnson & Johnson Vision. Speaker’s Bureau: Eaglet Eye and CooperVision Specialty EyeCare

      Muriel Schornack, OD, FAAO, FSLS has had no financial relationship or affiliation with ineligible companies.

      Christine Sindt, OD, FAAO, FSLS has had a financial relationship or affiliation with the following ineligible companies in the form of Owner/Employee: EyePrint Prosthetics

      Minh Anh Tran, OD has had no financial relationship or affiliation with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Avenue Live.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Expiration Date:

    5.00 credits
    Completing the pre-test is required to access this content.
    Completing the pre-survey is required to view this content.

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    Register

    We're glad to see you're enjoying Evolve Medical Education…
    but how about a more personalized experience?

    Register for free